Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRYPTOPHAN for Dementia alzheimer's type: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TRYPTOPHAN was used for Dementia alzheimer's type.

Most Reported Side Effects for TRYPTOPHAN

Side Effect Reports % Deaths Hosp.
Hypotension 25 24.8% 0 7
Drug hypersensitivity 23 22.8% 0 0
Product use in unapproved indication 23 22.8% 0 7
Drug ineffective 21 20.8% 0 2
Migraine 19 18.8% 0 1
Drug intolerance 18 17.8% 0 0
Bronchial hyperreactivity 17 16.8% 0 0
Taste disorder 17 16.8% 0 1
Asthma 16 15.8% 0 0
Influenza like illness 16 15.8% 0 0
Myocardial infarction 16 15.8% 0 0
Product use complaint 16 15.8% 0 0
Pruritus 16 15.8% 0 0
Breast disorder 15 14.9% 0 0
Toxicity to various agents 14 13.9% 7 11

Other Indications for TRYPTOPHAN

Product used for unknown indication (48) Migraine (19)

Other Drugs Used for Dementia alzheimer's type

RIVASTIGMINE (2,781) DONEPEZIL (2,313) LECANEMAB-IRMB (1,473) MEMANTINE (1,335) GALANTAMINE (468) BREXPIPRAZOLE (381) DONANEMAB-AZBT (347) ADUCANUMAB-AVWA (341) EXELON (282) QUETIAPINE (200)

Related Pages

TRYPTOPHAN Full Profile All Dementia alzheimer's type Drugs TRYPTOPHAN Demographics TRYPTOPHAN Timeline